Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of cross-linked amylose as a matrix for the slow release of biologically active compounds

Use of cross-linked amylose as a matrix for the slow release of biologically active compounds

US Patent 5456921 · Granted Oct 10, 1995

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bioactive agents included in functionalized starch having a single helix V-struc2024
Mesalamine suppository2018
Oral enzyme compositions for intestinal delivery2018
Complex containing carboxyl substituted starch and lipid for delayed delivery of2015
Histaminase of vegetable origin for use in the treatment of allergic and septic 2014
Controlled-release compositions2013
Mesalamine suppository2013
Mesalamine suppository2012
Sustained-release tramadol formulations with 24-hour efficacy2011
Mesalamine suppository2009
Neuroprotective composition and uses thereof2005
Ceruloplasmin and an antioxidant composition comprising the same and their uses 2004